Transarterial Injection of <sup>131</sup>I-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer - Concepedia

Concepedia

Publication | Open Access

Transarterial Injection of <sup>131</sup>I-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer

DOI Full Paper Access

40

Citations

26

References

2009

Year

Laura Marelli, Vibhakorn Shusang, John Buscombe, Εvangelos Cholongitas, R. Stigliano, Neil M Davies, Jonathan Tibballs, David Patch, Tim Meyer, Andrew K. Burroughs

Journal of Nuclear Medicine

Abstract

In patients with unresectable HCC, there was no difference in survival between (131)I-lipiodol therapy and TACE/TAE treatment. However, in the patients with advanced clinical staging or PVT, there was a significant survival advantage for those treated with (131)I-lipiodol.

References

	Year	Citations

Page 1